HSP90AB1 and cancer: The leads were demonstrated to inhibit TRAP1, but not cytosolic Hsp90, ATPase activity, and revert TRAP1-dependent downregulation of succinate dehydrogenase activity in cancer cells, blocking tumorigenic growth of neoplastic cells53 (Figure 4).